Methods of treating neuroendocrine tumors using frizzled-binding agents
AssigneeOncoMed Pharmaceuticals, Inc.
InventorsRobert Joseph Stagg, Jakob Dupont
Life of this patent
Estimating the term…
Abstract
Novel methods of treating neuroendocrine tumors are provided. In one embodiment, the method comprises administering to a subject in need thereof a therapeutically effective dose of a Wnt antagonist. In one embodiment, the Wnt antagonist is an anti-FZD antibody. In another embodiment, the Wnt antagonist is a soluble FZD receptor polypeptide. In a further embodiment, the Wnt antagonist is an anti-Wnt antibody.
Claims38
1-6. (canceled)
A method of treating neuroendocrine cancer, comprising administering to a subject in need thereof a therapeutically effective amount of a Wnt antagonist.
9-10. (canceled)
14-16. (canceled)
18-21. (canceled)
(canceled)
(canceled)
(canceled)
35-36. (canceled)
(canceled)
45-48. (canceled)
50-52. (canceled)
55-56. (canceled)
Dependencies are inferred from the claim text.